Preparing for Cold & Allergy Season 2026: What Buyers Should Know About High-Demand Generics
Fall inventory planning happens on a deadline. Once the cold, flu, and allergy symptoms start showing up at the pharmacy counter, buyers who waited to place their orders are already behind.
Getting ahead of the cold and cough season means locking in your supply for the generics that your patients reach for most before demand peaks and allocation gets tight.
Why Does Early Planning Matter for Cold and Cough Generics?
Respiratory illness season comes suddenly. Last season, outpatient visits for influenza-like illness stayed above the national baseline for 17 consecutive weeks from November 2024 through March 2025. Activity peaked at 7.9% of visits during the week ending on February 8th, 2025, the highest level since the 2009-10 H1N1 pandemic season.
The compressed high-volume window leaves little room for reordering mid-surge. Planning ahead is critical for being prepared as the season's intensity builds. If you build your cough and cold inventory in September and October, your portfolio will still be fully stocked in January.
What High-Demand Categories Should Pharmaceutical Buyers Stock Now?
Combination cough and cold liquids see the heaviest turnover once symptoms hit, particularly for households managing both adult and pediatric patients. Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl covers the liquid format, and WesTussin DM and WesTussin DM NF round out the shelf with strength variations suited for different patient populations. For pharmacies or patients that prefer tablet formulations, the Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl tablet offers the same combination in a solid dose form.
On the prescription side, Codeine-Guaifenesin Oral Solution is a staple for patients who need a stronger antitussive than OTC options provide. Allergy overlap adds another layer to the seasonal demand, and antihistamine liquids like Triprolidine HCl fill that need for pharmacies serving patients dealing with both cold symptoms and seasonal allergies simultaneously.
What Should Pharmaceutical Buyers Ask Their Distributors?
Knowing which questions to ask now can prevent stockouts later:
• Confirm NDC level availability and law allocation before the season ramps up.
• Ask whether your distributors and manufacturer partners are FDA registered and how they've handled allocation during past high-demand periods.
• Take stock of your patient population: Pharmacies serving families with young children will want to weight orders toward liquid form formats, while those serving adult-heavy populations may lean toward tablet formats.
Talk to Your Rep Before the Rush
Cold and allergy season rewards buyers who plan early. Westminster Pharmaceuticals works with FDA-registered manufacturer partners to keep high-demand cough, cold, and antihistamine generics available when pharmacies need them. Reach out to your sales representative now to review your fall inventory plan and secure allocation ahead of the peak season.
